Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,175 trials

NCT07414212
Recruiting
Evaluation of the Combined Therapy of EH-301 and N-acetylcysteine Together With Riluzole in Amyotrophic Lateral Sclerosis (ALS)
Phase 1/2 · Spain · 1 site
Registry update: 17 Feb 2026
NCT07395973
Recruiting
The Effects of a 4-week Supplementation With a Ketogenic Nutrient Mix on 24-hour Substrate Metabolism and Muscle Health
Not applicable · Netherlands · 1 site
Registry update: 9 Feb 2026
NCT07833319
Recruiting
Local Methylene Blue Injection for Prevention of Anastomotic Leakage and Permanent Stoma After Low Anterior Resection for Rectal Cancer
Phase 2 · China · 1 site
Registry update: 22 Sept 2026
NCT07370766
Recruiting
Impact of Tildrakizumab on Patient Reported Outcomes in Patients With Moderate-to-severe Psoriasis in Canada
Not applicable · Canada · 7 sites
Registry update: 11 Sept 2026
NCT07312045
Recruiting
HALP Score, Blood-Based Inflammatory Indices, and Salivary MMP-8 in Periodontal Disease and Healing After Non-Surgical Therapy
Not applicable · 1 site
Registry update: 31 Dec 2025
NCT07468058
Recruiting
Diabetic Retinopathy Prevalence And Risk Factors
Not applicable · Vietnam · 1 site
Registry update: 12 Mar 2026
NCT07155174
Recruiting
A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination With Atezolizumab Versus Standard of Care as First-Line Treatment in Adult Participants With Previously Untreated Extensive Stage Small Cell Lung Cancer
Phase 2 · Belgium, China, Germany, Spain, Israel, Italy, Japan, South Korea, Poland, Serbia, Taiwan, United States · 74 sites
Registry update: 27 Oct 2026
NCT07211958
Recruiting
Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation
Phase 3 · Argentina, Austria, Australia, Belgium, Brazil, Canada, Czechia, Germany, Spain, France, United Kingdom, Georgia, Greece, Hungary, Israel, Italy, South Korea, Lithuania, Malaysia, Poland, Portugal, Romania, Singapore, United States · 187 sites
Registry update: 21 Oct 2026
2024-519779-24-00
Recruiting
Momelotinib in VEXAS syndrome
Phase 2 · France · 13 sites
Registry update: 19 Oct 2026
NCT07266662
Recruiting
Comparative Effects of Sensory Augmentation and Neuromodulation on Enhancing Motor Recovery Among Stroke Survivors
Not applicable · Pakistan · 2 sites
Registry update: 17 Dec 2025
NCT06902766
Recruiting
Towards Digital Management of Paediatric Asthma
Not applicable · France · 1 site
Registry update: 16 Oct 2026
NCT07142291
Recruiting
PHENOGENE-1A (Cromolyn) Treatment in Patients With Mild to Moderate ALS
Phase 2 · Czechia, Germany, Spain, Poland, Serbia, United States · 22 sites
Registry update: 23 Jul 2026
NCT07085429
Recruiting
Development of Clinical and Biological Database on Bronchial Cancer
Not applicable · France · 1 site
Registry update: 6 Nov 2026
NCT07018076
Recruiting
Candidate Clinical Correlate of Prognostic Outcome for TB Study
Not applicable · Uganda, Vietnam · 3 sites
Registry update: 20 Jul 2026
NCT07098936
Recruiting
Momelotinib in VEXAS Syndrome
Phase 2 · France · 11 sites
Registry update: 10 Aug 2026
2024-512922-27-00
Recruiting
PIRTOBRUTINIB AND GLOFITAMAB IN MANTLE CELL LYMPHOMA
Phase 2 · Germany, Denmark, Spain, Norway, Sweden · 33 sites
Registry update: 30 Sept 2026
NCT07334119
Recruiting
Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of MT-304 in Adults With Advanced HER2-Expressing Solid Tumors
Phase 1 · Australia · 7 sites
Registry update: 20 May 2026
NCT07176650
Recruiting
Phase I Clinical Study To Evaluate Pharmacokinetic Profile, Safety, Efficacy and Immunogenicity Of Ipilimumab Biosimilar HLX13 Vs. YERVOY® (US-Sourced YERVOY®) As A First-Line Treatment For Patients With Unresectable Hepatocellular Carcinoma
Phase 1 · China, United States · 51 sites
Registry update: 16 Mar 2026
NCT07061964
Recruiting
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
Phase 2 · United States · 182 sites
Registry update: 3 Nov 2026
NCT07275918
Recruiting
SA1211 Injection Phase 1 Study
Phase 1 · China · 1 site
Registry update: 10 Dec 2025

Ordered by registry start date. Freshness and sponsorship never change the order.